| 1 |
34878093 | Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up. | 2022 Jan 14 |
1 |
| 2 |
33734052 | Effects of Cardioprotective Tactics on the Myocardial Perfusion and Contractile Function of the Left Ventricular Myocardium in Cancer Patients with Evidence of Doxorubicin-Induced Cardiotoxicity. | 2021 Feb 10 |
1 |
| 3 |
33746165 | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy. | 2021 Sep 1 |
1 |
| 4 |
33946067 | Protective Effects of ACEI/ARB on Left Ventricular Function in Anthracycline-Induced Chronic Cardiotoxicity: A Meta-Analysis of Randomized Controlled Trials. | 2021 |
1 |
| 5 |
34951629 | A systematic review and meta-analysis of beta-blockers and renin-angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer. | 2021 Dec 24 |
2 |
| 6 |
31995035 | Anthracycline-induced cardiotoxicity prevention with angiotensin-converting enzyme inhibitor ramipril in women with low-risk breast cancer: results of a prospective randomized study. | 2020 Feb 25 |
1 |
| 7 |
31008768 | The Preventive Role of Angiotensin Converting Enzyme Inhibitors/Angiotensin-II Receptor Blockers and β-Adrenergic Blockers in Anthracycline- and Trastuzumab-Induced Cardiotoxicity. | 2019 Sep/Oct |
2 |
| 8 |
31171092 | Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer. | 2019 Jun 11 |
1 |
| 9 |
30009543 | Role of ACE inhibitors in anthracycline-induced cardiotoxicity: A randomized, double-blind, placebo-controlled trial. | 2018 Nov |
3 |
| 10 |
27830273 | [Summary of the ESC position paper on cancer treatment and cardiovascular toxicity]. | 2016 Dec |
1 |
| 11 |
24666651 | Cardiotoxicity and oncological treatments. | 2014 Mar 7 |
1 |
| 12 |
21221562 | Anthracycline-associated cardiotoxicity in survivors of childhood cancer. | 2011 Mar |
2 |
| 13 |
20872550 | Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up. | 2010 Nov |
1 |
| 14 |
19423276 | [Anthracycline-induced cardiomyopathy]. | 2009 Jun |
2 |
| 15 |
22505958 | Chemotherapy induced cardiomyopathy: pathogenesis, monitoring and management. | 2009 Apr |
2 |
| 16 |
15095572 | [ACE inhibitors in the treatment of ventricular dysfunction caused by cardiotoxic cytostatics]. | 2004 Mar |
3 |
| 17 |
11579345 | Design and baseline characteristics for the ACE Inhibitor After Anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors. | 2001 Oct |
2 |
| 18 |
9123633 | [Angiotensin-converting enzyme inhibitor in the treatment of epirubicin-induced dilated cardiomyopathy]. | 1997 Mar 24 |
1 |
| 19 |
8569365 | Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy. | 1996 Feb 3 |
1 |